Rethinking drugs

Sasha Breger Bush and Matthew Kriese

Review of Social Economy, 2020, vol. 78, issue 4, 479-506

Abstract: Discussions of drugs in international political economy tend to focus on the relative advantages and disadvantages of particular regulatory regimes and governmental policy approaches. While the particular regulation(s) and social context(s) differ, the drug literature is in this sense repetitive and neglectful of significant features of the global drug economy. Drawing on social economics, we argue that the neglect of broad and holistic, synthetic, integrative and comparative drug research in IPE stems in part from a research program in which the state is “essentialized”, resulting in drug research that is too narrowly cast. Borrowing from social economics, poststructuralist Marxism, and new materialism, we develop an anti-essentialist approach for thinking about the global drug economy in an effort to reveal aspects of global drug production, distribution and consumption, and the power relations entailed therein, that are currently obscured.

Date: 2020
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1080/00346764.2019.1605536 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:rsocec:v:78:y:2020:i:4:p:479-506

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/RRSE20

DOI: 10.1080/00346764.2019.1605536

Access Statistics for this article

Review of Social Economy is currently edited by Wilfred Dolfsma and John Davis

More articles in Review of Social Economy from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().